NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/06/2025
Voltar para busca
Dado oficial do USPTO
VIEDOC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
12/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 42
Data de depósito
26/09/2016
Data de registro
19/02/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/06/2025
Última transação
12/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/12/2007
Primeiro uso no comércio
15/12/2007
Código do desenho
4
Tipo de titular
99
Localização do titular
UPPSALA, SE
Examinador
YOUNG, THOMAS
Localização atual
Historical data usage
Titulares e representantes
Titulares
VIEDOC TECHNOLOGIES AB
PCG Solutions AB
Representantes
Christopher D. Casavale NELSON MULLINS RILEY & SCARBOROUGH LLP
Classificação técnica
Classes Nice
Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer software for conducting clinical trials and electronically managereview and report clinical trial data; Softwaresoftware for managing clinical trial management systems; Computer software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical research; Computer software for designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocols; Computer software for medical coding in medical clinical trials and medical research; Computer software for the collection of information and data in medical clinical trials and medical research; Computer software for evaluating and measuring the performance and results of medical clinical trials and medical research; Computer software for managingorganizing and reporting the results of medical clinical trials and medical research; Computer software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Computer software for medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management
Classe 42
Software as a service (SaaS) solutions featuring software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocols; Software as a service (SaaS) solutions featuring software for medical coding in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for the collection of information and data in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for evaluating and measuring the performance and results of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for capturingmanagingorganizing and reporting the results of medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Software as a service (SaaS) solutions featuring software for medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management; Providing temporary use of online non-downloadable computer software for capturingmanaging and reporting data and information in the fields of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for designingmanagingexecuting medical clinical trials and medical research and medical clinical trial and medical research protocols; Providing temporary use of online non-downloadable computer software for the collection of information and data in medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for evaluating and measuring the performance and results of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for managingorganizing and reporting the results of medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research; Providing temporary use of online non-downloadable computer software for medical clinical trial and medical research operational reporting and analyticsfor medical clinical trial and medical research patient randomization and supply management
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/06/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
26/02/2025
E815
TEAS SECTION 8 & 15 RECEIVED
18/02/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
19/02/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/01/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/01/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/01/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/01/2019
IUAF
USE AMENDMENT FILED
13/12/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/12/2018
EISU
TEAS STATEMENT OF USE RECEIVED
13/12/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/07/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/05/2018
PUBO
PUBLISHED FOR OPPOSITION
29/05/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/04/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/04/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/04/2018
ALIE
ASSIGNED TO LIE
19/04/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/04/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/01/2018
GNSL
LETTER OF SUSPENSION E-MAILED
05/01/2018
CNSL
SUSPENSION LETTER WRITTEN
05/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/12/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/12/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/06/2017
GNFR
FINAL REFUSAL E-MAILED
29/06/2017
CNFR
FINAL REFUSAL WRITTEN
29/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/06/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/06/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/01/2017
GNRT
NON-FINAL ACTION E-MAILED
03/01/2017
CNRT
NON-FINAL ACTION WRITTEN
03/01/2017
DOCK
ASSIGNED TO EXAMINER
03/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/09/2016
NWAP
NEW APPLICATION ENTERED
29/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIEDOC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.